Condition
Advanced Lung Disease
Total Trials
5
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed4
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03562728Not ApplicableActive Not RecruitingPrimary
Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease
NCT03457545Not ApplicableCompletedPrimary
Treating Frailty in Lung Transplant Candidates (PREHAB)
NCT04184180CompletedPrimary
Effects of Inpatient Pulmonary Rehabilitation on Frailty in Patients After Lung-Transplantation
NCT03895931CompletedPrimary
Effect of Inpatient Pulmonary Rehabilitation on Frailty in Candidates for Lung-Transplantation
NCT02390219Phase 3Completed
Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease
Showing all 5 trials